- 2.9Impact Factor
- 5.2CiteScore
- 18 daysTime to First Decision
Clinical Advances in Inflammatory Bowel Disease: 2nd Edition
This special issue belongs to the section “Gastroenterology & Hepatopancreatobiliary Medicine“.
Special Issue Information
Dear Colleagues,
It is my pleasure to invite you to contribute to the Special Issue entitled “Clinical Advances in Inflammatory Bowel Disease: 2nd Edition”. This will build upon the first edition focusing on this theme (https://www.mdpi.com/journal/jcm/special_issues/LM2O74CR01).
The incidence of Inflammatory Bowel Diseases (IBDs) has significantly increased in recent decades. This has led to an ever-greater impact of these diseases on society, since the vast majority of patients with IBD are of working age. Fortunately, in recent years, several different drugs with different mechanisms of action have been approved or are about to be approved for clinical practice. Therefore, clinicians involved in IBD management will have an increased therapeutic armamentarium. Over the coming years, studies will analyze the effectiveness of these drugs in real-world clinical practice. Furthermore, IBD research should focus on the important issue of the choice of the right drug for the right patient at the right time. This personalized approach could significantly reduce health care expenditure and also maximize therapeutic response rates. This Special Issue of JCM will provide an important opportunity to publish studies addressing these points, which would have a significant impact on the clinical management of IBD in the near future.
Dr. Lorenzo Bertani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel diseases
- IBD
- Crohn’s disease
- ulcerative colitis
- biomarkers
- biologics
- anti-JAKs
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

